In 2024, the health tech sector demonstrates resilience, with a notable recovery in public market performance and a surge in AI-driven innovations. Investors are increasingly focused on profitability and efficient growth, as companies like Tempus and Waystar join the health tech index, reflecting a market capitalization of $98 billion. The rise of AI Services-as-Software is reshaping the landscape, showcasing rapid growth and shorter sales cycles, while private equity firms capitalize on low valuations through significant take-private transactions.
